Evidence map›Paper›PMID 27223324›Full record

ArticleeLife2016

PHF13 is a molecular reader and transcriptional co-regulator of H3K4me2/3.

Ho-Ryun Chung, Chao Xu, Alisa Fuchs, Andreas Mund, Martin Lange, Hannah Staege, Tobias Schubert, Chuanbing Bian, Ilona Dunkel, Anton Eberharter and 9 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Tuning the Orchestra: HCMV vs. Innate Immunity.Frontiers in microbiology · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 7 countries.

Ho-Ryun ChungMax Planck Institute for Molecular Genetics, Berlin, Germany.
Chao XuStructural Genomics Consortium, Toronto, Canada.ORCID 0000-0003-0444-7080
Alisa FuchsMax Planck Institute for Molecular Genetics, Berlin, Germany.
Andreas MundHeinrich-Pette-Institute - Leibniz Institute for Experimental Virology, Hamburg, Germany.
Martin LangeCentre for Genomic Regulation, Barcelona, Spain.ORCID 0000-0003-1650-533X
Hannah StaegeHeinrich-Pette-Institute - Leibniz Institute for Experimental Virology, Hamburg, Germany.
Tobias SchubertHeinrich-Pette-Institute - Leibniz Institute for Experimental Virology, Hamburg, Germany.
Chuanbing BianStructural Genomics Consortium, Toronto, Canada.
Ilona DunkelMax Planck Institute for Molecular Genetics, Berlin, Germany.
Anton EberharterAdolf-Butenandt-Institute and Center for Integrated Protein Science, Ludwig-Maximilians-University, Munich, Germany.
Catherine RegnardAdolf-Butenandt-Institute and Center for Integrated Protein Science, Ludwig-Maximilians-University, Munich, Germany.
Henrike KlinkerAdolf-Butenandt-Institute and Center for Integrated Protein Science, Ludwig-Maximilians-University, Munich, Germany.
David MeierhoferMax Planck Institute for Molecular Genetics, Berlin, Germany.
Luca CozzutoCentre for Genomic Regulation, Barcelona, Spain.ORCID 0000-0003-3194-8892
Andreas WinterpachtHuman Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Luciano Di CroceCentre for Genomic Regulation, Barcelona, Spain.
Jinrong MinStructural Genomics Consortium, Toronto, Canada.
Hans WillHeinrich-Pette-Institute - Leibniz Institute for Experimental Virology, Hamburg, Germany.
Sarah KinkleyMax Planck Institute for Molecular Genetics, Berlin, Germany.ORCID 0000-0003-4997-4749
Leibniz Institute of Virology (LIV) · DEMax Planck Institute for Molecular Genetics · DECenter for Integrated Protein Science Munich · DEStructural Genomics Consortium · CACentre for Genomic Regulation · ESFriedrich-Alexander-Universität Erlangen-Nürnberg · DEInstitució Catalana de Recerca i Estudis Avançats · ESUniversitat Pompeu Fabra · ESUniversity of Copenhagen · DKUniversity of Science and Technology of China · CN

Funding

Wellcome Trust
6 · The paper itself

Abstract

PHF13 is a chromatin affiliated protein with a functional role in differentiation, cell division, DNA damage response and higher chromatin order. To gain insight into PHF13's ability to modulate these processes, we elucidate the mechanisms targeting PHF13 to chromatin, its genome wide localization and its molecular chromatin context. Size exclusion chromatography, mass spectrometry, X-ray crystallography and ChIP sequencing demonstrate that PHF13 binds chromatin in a multivalent fashion via direct interactions with H3K4me2/3 and DNA, and indirectly via interactions with PRC2 and RNA PolII. Furthermore, PHF13 depletion disrupted the interactions between PRC2, RNA PolII S5P, H3K4me3 and H3K27me3 and resulted in the up and down regulation of genes functionally enriched in transcriptional regulation, DNA binding, cell cycle, differentiation and chromatin organization. Together our findings argue that PHF13 is an H3K4me2/3 molecular reader and transcriptional co-regulator, affording it the ability to impact different chromatin processes.

Indexed as

AnimalsCell LineChromatinChromatin ImmunoprecipitationChromatography, GelCrystallography, X-RayDNADNA-Binding ProteinsGene Expression RegulationHistonesHumansMass SpectrometryMiceProtein BindingTranscription FactorsChromatinDNADNA-Binding ProteinsHistonesPHF13 protein, humanTranscription Factorsbiophysicschromosomesgeneshumanmolecular reader and effectormousePHD domainPRC2RNA polymerase IIstructural biologytranscriptional regulator

Identifiers

PMID27223324
PMCPMC4915813
OpenAlexW2401592760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.